Skip to main content
. 2023 Feb 25;68(6):2291–2302. doi: 10.1007/s10620-023-07883-8

Table 1.

Participant demographics by insomnia status

Overall No insomnia (n = 156) Insomnia (n = 156) Significance test for insomnia vs no insomnia
Age in years M = 48.62 (SD = 16.10) M = 48.18 (SD = 16.31) M = 49.07 (SD = 15.93) t(307) = − 0.49, p = 0.63
Gender
 Women 207 (66.3%) 91 (58.3%) 116 (74.4%) X2(1, N = 311) = 8.55, p = 0.003
 Men 104 (33.3%) 64 (41.0%) 40 (25.6%)
 Other 1 (0.3%) 1 (0.6%) 0
Race/ethnicity
 African American/Black 1 (0.3%) 0 1 (0.6%) X2(5, 312) = 9.03, p = 0.11
 American Indian/Alaska Native 2 (0.6%) 2 (0.6%) 0
 Asian 2 (0.6%) 0 2 (0.1.3%)
 Hispanic 2 (0.6%) 1 (0.6%) 1 (0.6%)
 White 299 (95.8%) 150 (96.2%) 149 (95.5%)
 Other 3 (1%) 3 (1%) 0
Inflammatory bowel disease
 Crohn’s disease
  Active 113 (36.5%) 39 (25.3%) 74 (47.4%) X2(1, 310) = 31.15, p < 0.001 for disease activity;
  Inactive 75 (24.2%) 50 (32.5%) 25 (16.0%)
 Ulcerative colitis
  Active 57 (18.4%) 21 (13.6%) 36 (23.1%) X2(1, 310) = 1.04, p = 0.31 for Crohn’s vs UC
  Inactive 65 (21.0%) 44 (28.6%) 21 (13.5%)
Age of IBD symptom onset in years M = 27.82 (SD = 15.66) M = 26.67 (SD = 14.89) M = 28.97 (SD = 16.36) t(309) = − 1.30, p = 0.20
Age of IBD diagnosis in years M = 32.34 (SD = 16.01) M = 31.45 (SD = 15.10) M = 33.22 (SD = 16.88) t(309) = − 0.97, p = 0.33

IBD inflammatory bowel disease